Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

PAYMENT LINK _ Drug Discovery Services Market by Process (Target Selection, Hit-to-Lead Identification, Lead Optimization), Type (Medicinal Chemistry, Biology Services, DMPK), Drug Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, Neurology) - Forecast to 2022

  • Report Code: DR 1000
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

PAYMENT LINK _ Drug Discovery Services Market by Process (Target Selection, Hit-to-Lead Identification, Lead Optimization), Type (Medicinal Chemistry, Biology Services, DMPK), Drug Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, Neurology) - Forecast to 2022



1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Submarkets
4.1 Injectables Drug Delivery devices
4.2 Respiratory drug delivery devices
4.3 Implantable Drug Delivery Devices
4.4 Intranasal Drug Delivery Systems
4.5 Transdermal Drug Delivery Systems
5 By Technologies
5.1 Smart Pill Technology (SPT)
5.2 Microfluidics
6 By Groups
6.1 Pharmaceutical Packaging

Please fill in the form below to receive a free copy of the Summary of this Report
















PAYMENT LINK _ Drug Discovery Services Market by Process (Target Selection, Hit-to-Lead Identification, Lead Optimization), Type (Medicinal Chemistry, Biology Services, DMPK), Drug Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, Neurology) - Forecast to 2022

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE PUBLISHED
Global Injectables Drug Delivery devices Market Global Injectables Drug Delivery devices Market
The Global Injectable Drug Delivery Devices Market is mainly driven by growing prevalence of target disease segments such as diabetes, multiple sclerosis, Crohn’s disease, rheumatoid arthritis, psoriasis, reproductive diseases and cancer. The Market was Valued at $11.86 billion in 2013 and expected to be $20.04 billion by 2018, growing at a CAGR of 11.1%. The Injectable Drug Delivery Devices Market analyzes the market by segments such as Conventional injectable devices, Self injection devices, other injectable devices.The prominent players in the Market are Becton Dickinson and Co., Terumo Corporation, Baxter International Inc., Antares Pharma Inc., West Pharmaceutical Services Inc., Haselmeier GmbH, Ypsomed Holding AG, and Nova Nordisk A/S.
Upcoming
Global Implantable Drug Delivery Devices Market Global Implantable Drug Delivery Devices Market
The Global Implantable Drug Delivery Market is mainly driven by growing prevalence of target disease segments such as Prostate Cancer, diabetic retinopathy, chronic pain causing diseases, cardiovascular diseases, Colorectal Cancer, and a rapid aging global population.The Market was Valued at $9.05 billion in 2013 and expected to be $12.42 billion by 2018, growing at a CAGR of 6.5 %. The Implantable Drug Delivery Market analyzes the market by segments such as Drug eluting stents, Infusion Pumps, Intraocular Implants, Brachytherapy Seeds, Contraceptive Implants.The prominent players in the Market are Boston Scientific, Abbott Laboratories, Medtronic, Allergen INC, Merck, Bayer Pharma AG, Arrow International, Theragenics, Varian Medical Systems, and Eckert Ziegler.
Upcoming
Intranasal Drug Delivery Systems Intranasal Drug Delivery Systems
Intranasal Drug Delivery Systems and Injectables Drug Delivery devices,
Upcoming
Global Transdermal Drug Delivery Systems Market Global Transdermal Drug Delivery Systems Market
The Global Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies on in-house capabilities for the development of oral drug delivery technologies.The Market was Valued at $13.5 billion in 2013 and expected to be $21.7 billion by 2018, growing at a CAGR of 11.1%. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
Drug Eluting Stents Drug Eluting Stents
Drug Eluting Stents and Infusion Pumps, Contraceptive...
Upcoming
Infusion Pumps Infusion Pumps
Infusion Pumps and Drug Eluting Stents, Contraceptive...
Upcoming
Contraceptive Implants Contraceptive Implants
Contraceptive Implants and Drug Eluting Stents, Infusion Pumps,...
Upcoming
Intravitreal Implants Intravitreal Implants
Intravitreal Implants and Drug Eluting Stents, Infusion Pumps,...
Upcoming
Conventional Injectable Drug delivery Devices Conventional Injectable Drug delivery Devices
Conventional Injectable Drug delivery Devices and Self-injection Devices and Microneedles adds up to total
Upcoming
Self-injection Devices Self-injection Devices
Self-injection Devices and Conventional Injectable Drug delivery Devices and Microneedles adds up to total
Upcoming
Brachytherapy seed Brachytherapy seed
Brachytherapy seed and Drug Eluting Stents, Infusion Pumps,
Upcoming
Nasal Spray Nasal Spray
Nasal Spray and Nasal Inhalers adds up to total
Upcoming
Nasal Inhalers Nasal Inhalers
Nasal Inhalers and Nasal Spray adds up to total
Upcoming
Global Passive Transdermal Drug Delivery Market Global Passive Transdermal Drug Delivery Market
The Global Passive Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs, huge investment made by big pharmaceutical companies.The Market was Valued at $12.27 billion in 2013 and expected to be $20.59 billion by 2018, growing at a CAGR of 10.9 %. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
Active Active
Active and Microfluidics, Smart Pill Technology (SPT) and Passive adds up to...
Upcoming
Prefilled Prefilled
Prefilled and Fillable adds up to total Injectables Drug...
Upcoming
Fillable Fillable
Fillable and Prefilled adds up to total Injectables Drug...
Upcoming
Disposable Disposable
Disposable and Reusable adds up to total Injectables Drug...
Upcoming
Reusable Reusable
Reusable and Disposable adds up to total Injectables Drug...
Upcoming
Standardized Auto Injectors Standardized Auto Injectors
Standardized Auto Injectors and Customized Auto Injectors adds up to total
Upcoming
61 reports | Show
Connect With Us
US/CAN : +1-888-502-0539
PAYMENT LINK _ Drug Discovery Services Market by Process (Target Selection, Hit-to-Lead Identification, Lead Optimization), Type (Medicinal Chemistry, Biology Services, DMPK), Drug Type (Small Molecules, Biologics), Therapeutic Areas (Oncology, Neurology) - Forecast to 2022